Sorry for my delayed response to you. I've been very busy with family issues. My answer to your question can be summarized in two words - - - "no impact". I look for UPI to do very well in 2013 and I dare say it will become an eventual target take-over by one of the larger companies in the medical field. I fully intend to say the course here with the expectation of putting together a share price of $8.00 to 10.00/share over the next 12 to 36 months. I currently own 23,000 shares - average cost at $3.3274. Although UPI is currently down from my average cost, that matter can be corrected in very short order given what I expect will be on-going growth in revenue with better and better financials through 2013 and into 2014. I currently consider UPI as a very "strong buy".